128 related articles for article (PubMed ID: 11418479)
1. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression.
Shapiro VS; Mollenauer MN; Weiss A
Blood; 2001 Jul; 98(1):187-93. PubMed ID: 11418479
[TBL] [Abstract][Full Text] [Related]
2. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.
Shapiro VS; Truitt KE; Imboden JB; Weiss A
Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
Shapiro VS; Mollenauer MN; Weiss A
J Immunol; 1998 Dec; 161(12):6455-8. PubMed ID: 9862666
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of ALX, an adaptor downstream of CD28.
Greene TA; Powell P; Nzerem C; Shapiro MJ; Shapiro VS
J Biol Chem; 2003 Nov; 278(46):45128-34. PubMed ID: 12960172
[TBL] [Abstract][Full Text] [Related]
5. The ALX Src homology 2 domain is both necessary and sufficient to inhibit T cell receptor/CD28-mediated up-regulation of RE/AP.
Shapiro MJ; Powell P; Ndubuizu A; Nzerem C; Shapiro VS
J Biol Chem; 2004 Sep; 279(39):40647-52. PubMed ID: 15284240
[TBL] [Abstract][Full Text] [Related]
6. Malignant plasma cell lines express a functional CD28 molecule.
Zhang XG; Olive D; Devos J; Rebouissou C; Ghiotto-Ragueneau M; Ferlin M; Klein B
Leukemia; 1998 Apr; 12(4):610-8. PubMed ID: 9557621
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
8. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation.
Faris M; Kokot N; Lee L; Nel AE
J Biol Chem; 1996 Nov; 271(44):27366-73. PubMed ID: 8910314
[TBL] [Abstract][Full Text] [Related]
9. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
[TBL] [Abstract][Full Text] [Related]
10. Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element.
Crist SA; Griffith TS; Ratliff TL
J Biol Chem; 2003 Sep; 278(38):35950-8. PubMed ID: 12855690
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of human CD28 in murine T cell hybridomas.
Couez D; Pagès F; Ragueneau M; Nunès J; Klasen S; Mawas C; Truneh A; Olive D
Mol Immunol; 1994 Jan; 31(1):47-57. PubMed ID: 8302298
[TBL] [Abstract][Full Text] [Related]
12. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation.
Fraser JD; Newton ME; Weiss A
J Exp Med; 1992 Apr; 175(4):1131-4. PubMed ID: 1313075
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells.
Tao L; Wadsworth S; Mercer J; Mueller C; Lynn K; Siekierka J; August A
Biochem J; 2002 Apr; 363(Pt 1):175-82. PubMed ID: 11903060
[TBL] [Abstract][Full Text] [Related]
14. Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription.
Sanchez-Lockhart M; Miller J
J Immunol; 2006 Apr; 176(8):4778-84. PubMed ID: 16585571
[TBL] [Abstract][Full Text] [Related]
15. CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.
Kunkl M; Mastrogiovanni M; Porciello N; Caristi S; Monteleone E; Arcieri S; Tuosto L
Front Immunol; 2019; 10():864. PubMed ID: 31068940
[TBL] [Abstract][Full Text] [Related]
16. CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
Nair JR; Carlson LM; Koorella C; Rozanski CH; Byrne GE; Bergsagel PL; Shaughnessy JP; Boise LH; Chanan-Khan A; Lee KP
J Immunol; 2011 Aug; 187(3):1243-53. PubMed ID: 21715687
[TBL] [Abstract][Full Text] [Related]
17. A transcriptional block in the IL-2 promoter at the -150 AP-1 site in effector CD8+ T cells.
Finch RJ; Fields PE; Greenberg PD
J Immunol; 2001 Jun; 166(11):6530-6. PubMed ID: 11359804
[TBL] [Abstract][Full Text] [Related]
18. The carboxyl-terminal segment of the adaptor protein ALX directs its nuclear export during T cell activation.
Shapiro MJ; Chen YY; Shapiro VS
J Biol Chem; 2005 Nov; 280(46):38242-6. PubMed ID: 16169852
[TBL] [Abstract][Full Text] [Related]
19. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2.
Lindgren H; Axcrona K; Leanderson T
J Immunol; 2001 Apr; 166(7):4578-85. PubMed ID: 11254715
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.
Gringhuis SI; de Leij LF; Verschuren EW; Borger P; Vellenga E
Blood; 1997 Oct; 90(7):2690-700. PubMed ID: 9326236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
